Shopping Cart
Remove All
Your shopping cart is currently empty
Lipopolysaccharides, from E. coli O128:B12 (LPS, from Escherichia coli [O128:B12]) are lipid polysaccharide endotoxins and TLR-4 activators derived from E. coli O128:B12, characterized as a smooth (S) type LPS. This compound features a typical three-part structure: O antigen, R3 core oligosaccharide, and lipid A. It activates TLR-4 in immune cells, is useful for developing neonatal brain inflammation models in animals, and may impact preterm birth in neonates.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry | |
| 100 mg | Inquiry | Inquiry | Inquiry |
| Description | Lipopolysaccharides, from E. coli O128:B12 (LPS, from Escherichia coli [O128:B12]) are lipid polysaccharide endotoxins and TLR-4 activators derived from E. coli O128:B12, characterized as a smooth (S) type LPS. This compound features a typical three-part structure: O antigen, R3 core oligosaccharide, and lipid A. It activates TLR-4 in immune cells, is useful for developing neonatal brain inflammation models in animals, and may impact preterm birth in neonates. |
| Synonyms | LPS, from Escherichia coli (O128:B12), Lipopolysaccharides (from E. coli O128:B12) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.